Informed Consent and Shared Decision-Making: A Requirement to Disclose to Patients Off-Label Prescriptions

1. BegleyS

2008 April 21

A new reason to frown. Newsweek.

Available: http://www.newsweek.com/id/131749?tid=relatedcl. Accessed 15 October 2008

2. ArbitlitDCFleishmanW

2005

The risky business of off-label use.

Trial

41

46

Available: http://www.lieffcabraser.com/pdf/20050405_fleishman_arbitblit_trial_offlabel.pdf. Accessed 9 October 2008

3. US Supreme Court

2001

Buckman Co. v. Plaintiffs' Legal Comm.

531 U.S. 341. Available: http://www.law.cornell.edu/supct/html/98-1768.ZO.html. Accessed 9 October 2008

4. SteinbrookR

2006

The price of sight—Ranibizumab, bevacizumab, and the treatment of macular degeneration.

N Engl J Med

355

1409

1412

5. O'ReillyJDalalA

2003

Off-label or out of bounds? Prescriber and marketer liability for unapproved uses of FDA-approved drugs.

Ann Health Law

12

295

324

6. RadleyDCFinkelsteinSNStaffordRS

2006

Off-label prescribing among office-based physicians.

Arch Intern Med

166

1021

1026

7. SalbuSR

1999

Off-label use, prescription, and marketing of FDA-approved drugs: An assessment of legislative and regulatory policy.

Fla Law Rev

51

181

211

8. StoffelmayrKJ

1996

Products liability and “off-label” uses of prescription drugs.

Univ Chic Law Rev

63

275

280

9. National Association of Attorneys General

2005

Addressing the cost and benefits of prescription drugs. 2005

Presidential Report

Washington (D. C.)

National Association of Attorneys General

10. AngellM

2006

The truth about the drug companies

New York

Random House

336

11. MoyerCA

2005

Off-label use and the Medical Negligence Standard under Minnesota law.

William Mitchell Law Rev

31

927

931

12. AdamsCYoungA

2003 November 3

Drug-makers' promotions boost off-label use by doctors. Knight Ridder Washington Bureau.

Available: http://www.accessmylibrary.com/coms2/summary_0286-8989915_ITM. Accessed 9 October 2008

13. RenniDFlanaginA

1994

Authorship! Authorship! Guests, ghosts, grafters, and the two-sided coin.

JAMA

271

469

471

14. FlanaginACareyLAFontanarosaPBPhillipsSGPaceBP

1998

Prevalence of articles with honorary authors and guest authors in peer-reviewed medical journals.

JAMA

280

222

224

15. KassirerJ

2005

On the take: How medicine's complicity with big business can endanger your health

New York

Oxford Press

272

16. KeltzJM

2003

Off-label use of prescription medication: Nursing implications.

Nephrol Nurs J

30

99

100

17. Supreme Court of Kansas

1960

Natanson v. Kline

350

P2d 1093

18. D. C. Circuit

1972

Canterbury v. Spence.

464 F.2d 772. Available: http://www.stanford.edu/group/psylawseminar/Canterbury.htm. Accessed 9 October 2008

19. Supreme Court of Oklahoma

1980

Scott v. Bradford. 606 P.2d 554.

Available: http://www.oscn.net/applications/oscn/DeliverDocument.asp?CiteID=48164. Accessed 9 October 2008

20. Pennsylvania Supreme Court

2001

Southard v. Temple University Hospital

781 A.2d 101

21. MorrisGH

2002

Discussing disclosure: Just what the doctor ordered.

Ariz Law Rev

44

313

326

22. BeckJMAzariED

1998

FDA, off-label drug use, and informed consent: Debunking myths and misconceptions.

Food Drug Cosmet Law J

53

71

104

23. 2006 April 20

Prescription facts to be computerized. San Francisco Chronicle.

24. AnsaniNSirioCSmithermanTFedutes-HendersonBSkledarS

2006

Designing a strategy to promote safe, innovative off-label use of medications.

Am J Med Qual

21

255

261

25. TorresA

1994

The use of Food and Drug Administration-Approved medications for unlabeled (off-label) uses.

Arch Dermatol

130

32

36

26. Ophthalmic Mutual Insurance Company

2004

Informed consent for off-label use of a drug or device.

Available: http://omic.com/resources/risk_man/forms.cfm. Accessed 15 October 2008